Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€64.76

€64.76

-4.370%
-2.96
-4.370%
-
 
09:09 / Tradegate WKN: A3ETYB / Name: Sandoz Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Sandoz Group AG Stock

Heavy losses for Sandoz Group AG today as the stock fell by -€2.960 (-4.370%).

Pros and Cons of Sandoz Group AG in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed
Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed
Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed
Sandoz signs landmark agreement with Rwandan government to ensure stable provision of critical medicines across selected African markets
Sandoz signs landmark agreement with Rwandan government to ensure stable provision of critical medicines across selected African markets
Sandoz signs landmark agreement with Rwandan government to ensure stable provision of critical medicines across selected African markets
Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide
Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide
Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide